Key cautions
- Cosmetic powder or serum is never an injectable or eye-drop substitute
What’s inside
A glycosaminoglycan chain built from repeating glucuronic-acid and N-acetylglucosamine units. Sodium hyaluronate retains this backbone as a sodium salt. Hydrolyzed, acetylated and cross-linked derivatives require their own identification; salt form alone does not specify molecular weight.
Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
Identity, source and modified forms
HA is a repeating-sugar polymer rather than a botanical oil or vitamin. The sodium salt is closely related, while hydrolysis, acetylation and cross-linking produce distinct materials. CIR’s 2023 review covers seven specified topical hyaluronates; cross-linked fillers were outside that review. Manufacturing source, molecular-weight distribution and product route therefore need to be checked independently.
EMBL-EBI ChEBI: Hyaluronic acid, CHEBI:16336 · Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
Molecular weight is chain size
Molecular weight describes the mass of the polymer chain; kDa means kilodaltons. A material can contain a distribution of chain sizes. Sodium hyaluronate identifies a salt, not one fixed chain length, and hydrolyzed material has undergone chain breakdown. These distinctions matter when comparing a supplier’s specification with a studied preparation.
Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
Ingredient solution versus finished formula
A supplied solution contains water as well as polymer, and a finished product may contain other humectants, oils, thickeners and preservatives. A percentage needs to identify what was measured: pure polymer, a supplied solution or the complete product. Thickness alone cannot establish polymer content or clinical benefit.
Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
Uses in brief
- Hydration and skin conditioning in finished topical products
- Potential improvement in dryness-related fine-line appearance, depending on the formula
History, folklore and reported uses
From eye research to a named molecule
Hyaluronic acid has a discovery story rather than an ancient herbal lineage. In 1933, Karl Meyer joined Columbia University's ophthalmology department and began investigating substances in the eye. The thick, transparent vitreous offered a promising material. In 1934, Meyer and John Palmer described the large sugar-based molecule they had isolated from cattle eyes; its name joined a reference to the vitreous with uronic acid, one of its chemical components. The National Academy of Sciences memoir follows the patient work that came afterward: nearly another quarter-century passed before the linkage of its two component sugars was correctly established.
National Academy of Sciences (2009): Karl Meyer memoir and the 1934 discovery of hyaluronan
Fermentation and the modern serum
Its later beauty history belongs to manufacturing as much as discovery. Shiseido's account places its large-scale cosmetic biotechnology production in the mid-1980s, and a fermentation patent filed in 1985 provides a contemporary documentary anchor. Fermentation helped build a different supply route from animal-tissue extraction. The modern serum bottle therefore carries a history of carbohydrate chemistry, microbial production and cosmetic formulation. Its association with naturally moist, supple skin grew from studying a substance already present in bodies, rather than from an inherited plant remedy or a newly discovered rejuvenating spring.
Shiseido: Expert Craftsmanship in Skincare, manufacturer’s account of 1985 hyaluronic-acid production · Akasaka, Komasaki and Arai: US4801539A, Fermentation method for producing hyaluronic acid, filed 1985
Moisture-retaining skin care
Modern creams and serums use hyaluronic acid and sodium hyaluronate as water-binding skin-conditioning ingredients. This cosmetic use grew from twentieth-century biomaterial chemistry and manufacturing, rather than inherited herbal practice.
Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
Dry-eye lubricants
Purpose-made sterile hyaluronate eye drops are used in modern dry-eye care; FDA’s material review examines this distinct product category. Facial serums and cosmetic raw materials are not eye-drop substitutes.
FDA/ECRI (2021): Hyaluronic Acid Medical Device Material Safety Summary
Protecting tissues during eye surgery
Ophthalmic viscoelastic preparations containing sodium hyaluronate help maintain space and protect tissues during operations such as cataract surgery. FDA’s ClearVisc record documents this professional surgical application.
FDA (2021): ClearVisc ophthalmic viscosurgical device, P200025
Knee-joint injections
Modern viscosupplementation places a medical hyaluronic-acid preparation inside an arthritic knee with the aim of improving joint lubrication and easing symptoms. AAOS describes this professional medical practice separately from cosmetic skin care.
American Academy of Orthopaedic Surgeons: Viscosupplementation for knee arthritis
Dermal filling and volume restoration
Crosslinked hyaluronic acid is used in regulated injectable fillers for specified wrinkles and volume deficits. These professional medical products are separate from skin-care serums, and injection into a blood vessel can cause tissue death or blindness.
FDA: Approved dermal fillers and hyaluronic-acid sources · FDA: Dermal fillers, approved uses and serious injection risks
Identity & detailed reference
Identity
Hyaluronic acid (hyaluronan, HA) is a water-binding polysaccharide found in animal connective tissues. Sodium hyaluronate is its sodium salt. Commercial cosmetic materials may be fermentation-derived or animal-derived and vary greatly in chain length.
Ingredient details, preparation and research
Source plant or material
Not a plant extract. Cosmetic HA can be made by bacterial fermentation or extracted from animal tissues such as rooster combs. Fermentation feedstocks do not turn the purified polymer into a botanical; confirm the actual supplier’s sourcing if animal origin matters.
Plant family / material: Not applicable: a microbial- or animal-derived polysaccharide rather than an herb.
Forms and route
Cosmetic powders, aqueous ingredient solutions, serums, creams and hair products; separately, oral supplements and product-specific medical preparations. Injectable fillers, joint injections and ophthalmic products are not interchangeable with cosmetic powders or serums.
Food sources
This is a cosmetic-material entry, with oral supplements discussed separately. No food serving, HA-rich meal plan or supplement dose is assigned; animal origin and oral suitability must be confirmed for the actual product.
Vitamins and minerals
HA is not a vitamin or mineral, and no dietary nutrient amount or Daily Value is assigned. Sodium in a cosmetic ingredient name does not turn a serum into a nutritional sodium source.
Absorption and preparation
High-molecular-weight HA mostly acts at the surface; smaller chains can penetrate farther in experimental skin studies, depending on the vehicle and skin model. Local hydration does not require delivery to the dermis. Oral absorption is a different question: rat experiments implicate intestinal breakdown and uptake of smaller fragments, not proven intact delivery of an oral polymer to human facial skin.
Practical preparation
Choose a properly preserved finished product and follow its directions. For dry skin, moisturizer on damp skin can help. Do not assume that a prepared solution’s stated percentage describes pure-polymer content, or mix an aqueous HA solution into carrier oil expecting a stable product.
Combination notes
HA and glycerin can appear together with emollients and occlusives in a moisturizer. Benefits reported for a multi-ingredient cream cannot be credited to HA alone. A botanical, oil or additional HA size does not automatically improve penetration, preservation or clinical effectiveness.
Traditional and reported uses
- Modern topical humectant and conditioning ingredient: can improve skin hydration and the appearance of some fine lines in tested formulas.
- Some small controlled trials favor lower molecular weights for particular outcomes; this does not establish that the smallest molecule or a multi-weight label is always best.
- Oral supplements have separate short-term human trials. Filler, joint and eye uses require their own medical products and evidence.
Contraindications and cautions
- Use a finished product intended for the relevant body area. Cosmetic HA must not be injected or substituted for sterile eye drops, surgical materials or joint preparations.
- Powder mixed with water is not automatically sterile or preserved. A water-based serum needs appropriate microbial protection; refrigeration or added glycerin does not validate its shelf life.
- Stop for irritation or rash. The complete formula and source impurities matter; ask about animal-derived material when relevant.
- Short-term oral studies in healthy adults do not establish long-term safety, disease treatment, or suitability during pregnancy, breastfeeding or childhood. Seek individual advice before using a supplement in these circumstances.
Similar items and how they compare
- Glycerin
Both are humectants used to support skin hydration.
Glycerol is a small polyol; HA is a much larger, chain-length-variable polymer.
- Sodium hyaluronate
The sodium salt shares the HA backbone and is often included under HA skin-care claims.
Its ingredient name identifies the salt, not an automatically smaller molecular weight or deeper penetration.
- Petrolatum
Both may be used as parts of dry-skin care.
Petrolatum primarily reduces water loss through occlusion; HA is a water-binding polymer. A humectant serum may not meet all of very dry skin’s needs.
History: a modern biomaterial
Meyer and Palmer described HA isolated from cattle-eye vitreous in 1934, as documented in the National Academy of Sciences memoir. This laboratory history does not establish a traditional herbal remedy. Present-day fermentation, cosmetic hydration and medical-device uses developed along separate manufacturing and clinical paths.
Topical facial evidence
In a 2011 trial, 76 women used one of several HA creams around one eye and vehicle around the other for 60 days. All tested HA formulations improved measured hydration and elasticity versus vehicle; two lower-molecular-weight groups also improved wrinkle-depth measures. This is evidence for those formulations and short-term outcomes, not proof of permanent rejuvenation, tissue replacement or equivalence to an injectable filler.
A newer molecular-weight comparison
A four-week randomized, double-blind study in 36 nursing-home residents aged 60–80 compared low- and high-molecular-weight HA lotions with vehicle at separate leg sites. Low-molecular-weight HA improved capacitance-based hydration more than the other two, but the groups did not differ significantly in water loss or the symptom score. This helps separate a hydration advantage from a demonstrated improvement in every clinically relevant outcome.
Penetration: size matters, but context does too
Raman imaging of excised human skin found penetration through the stratum corneum with the tested lower-molecular-weight HAs, unlike the largest tested chains. An experimental skin-section result is not proof that any commercial serum reaches or replenishes the dermis in daily use. Neither “sodium hyaluronate” nor a count of molecular-weight types establishes an optimal product; compare finished-product evidence rather than assuming deeper or smaller is always better.
What dry-air claims can and cannot say
In a small exploratory human skin-explant experiment, both HA and glycerin increased corneometer hydration readings, although the HA response was smaller under dry ambient conditions. Microscopy and bulk hydration readings did not tell an identical story. This does not establish a universal rule that HA dehydrates living skin below a particular humidity. AAD instead recommends suitable creams/ointments, moisturizer on damp skin and measures to address a dry environment.
Oral evidence must stay separate
A 2017 placebo-controlled study of 60 adults reported improvement in some wrinkle measures over 12 weeks; several authors worked for the ingredient manufacturer. A newer 150-person, 12-week trial published in December 2025 reported improvements in hydration and several other skin measures with oral sodium hyaluronate. Six of seven authors were manufacturer employees, and ClinicalTrials.gov registration was retrospective, although a separate EFSA filing preceded the trial. These encouraging, product-specific findings warrant independent confirmation and do not establish long-term or disease-treatment benefits.
Oral absorption is not a skin-penetration claim
Kimura and colleagues studied rat intestinal contents, excised intestinal tissue and orally dosed rats. Their results support bacterial breakdown to smaller HA fragments and subsequent uptake and tissue distribution. They do not measure intact oral HA delivery to human facial skin or identify a food pairing that reliably improves clinical results. Oral and topical molecular-weight claims should not be transferred between routes.
Injected fillers and joint preparations
FDA regulates dermal fillers as product-specific medical devices; injection can cause infection, nodules and, if a vessel is blocked, tissue death, blindness or stroke. This risk belongs to an invasive procedure and should not be confused with ordinary topical use. Knee viscosupplementation is another distinct clinical use; AAOS describes limited evidence of meaningful pain/function improvement. None of these indications justifies DIY injection or proves that a serum or capsule treats arthritis.
Preservation, storage and route safety
Water-based cosmetics need microbial safety appropriate to the complete product. FDA warns that contamination may come from raw materials, added water, poor preservation or handling. Hydrating a powder, refrigerating a mixture or adding another humectant does not demonstrate that it is preserved, sterile or suitable for an eye. Follow the labeled route and storage instructions; no home formulation, injection method or shelf-life recipe is provided.
Clinical limits and related ingredients
CIR’s topical safety assessment is not proof that HA cures eczema, acne, wounds or hair loss. AAD recommends clinical review for persistent dry skin because underlying disease may need specific treatment. Glycerin is a smaller humectant; petrolatum serves a different moisture-retention role. Neither topical use nor the ingredient’s sodium salt name establishes a dietary micronutrient benefit.
Entry sources
- Cosmetic Ingredient Review (2023): Safety assessment of hyaluronates as used in cosmetics
- EMBL-EBI ChEBI: Hyaluronic acid, CHEBI:16336
- Pavicic et al. (2011): Controlled trial of different-molecular-weight hyaluronan creams
- Muhammad et al. (2024): Molecular-weight comparison in 36 older adults with dry skin
- American Academy of Dermatology: Dermatologists' top tips for relieving dry skin
- National Academy of Sciences (2009): Karl Meyer memoir and the 1934 discovery of hyaluronan
- Essendoubi et al. (2016): Human skin penetration of different-molecular-weight hyaluronic acids
- Osseiran et al. (2018): Human skin-explant hydration under different environmental conditions
- Oe et al. (2017): Twelve-week placebo-controlled oral hyaluronan trial in 60 adults
- Dolečková et al. (2025): Twelve-week oral sodium-hyaluronate trial in 150 healthy adults
- Kimura et al. (2016): Oral hyaluronan degradation and absorption in rat experiments
- FDA: Dermal fillers, approved uses and serious injection risks
- FDA: Approved dermal fillers and hyaluronic-acid sources
- American Academy of Orthopaedic Surgeons: Viscosupplementation for knee arthritis
- FDA: Microbiological safety and cosmetics
Reference entry 80 · Recorded content review: 2026-10-05 · Review scope and dates


